Streetbeat News

Stock Prices

TGI

Triumph Group shares are experiencing an uptick in trading activity following reports that the company is considering a sale.

Portfolio Pulse from Benzinga Newsdesk

October 10, 2024 | 7:45 pm

GSK

PFE

GSK and Pfizer shares are trading lower due to potential declining sales of their Respiratory Syncytial Virus (RSV) vaccines. This follows the CDC's recommendation for a narrow age cohort for routine use.

Portfolio Pulse from Benzinga Newsdesk

October 10, 2024 | 7:44 pm

AU

AngloGold Ashanti shares rose following JP Morgan's decision to increase its price target from $32 to $37.

Portfolio Pulse from Benzinga Newsdesk

October 10, 2024 | 7:37 pm

RUN

Sunrun shares are experiencing a decline after Jefferies reduced its price target from $31 to $29.

Portfolio Pulse from Benzinga Newsdesk

October 10, 2024 | 7:34 pm

SPY

Scotiabank analyst Hugo Ste-Marie predicts that the technology sector will see a 15% increase in earnings year over year in Q3, while the energy sector is expected to face a 24% decline. The S&P 500, tracked by SPDR S&P 500 ETF Trust (NYSE:SPY), is anticipated to have modest earnings growth. Investors are likely to scrutinize Q3 numbers closely, but the earnings bar has been lowered since June.

Portfolio Pulse from Hayden Buckfire

October 10, 2024 | 7:34 pm

TGI

Triumph Group shares have resumed trading after a temporary halt. This development is significant for investors monitoring TGI's stock movements.

Portfolio Pulse from Benzinga Newsdesk

October 10, 2024 | 7:32 pm

SSNC

SS&C Technologies Holdings (NASDAQ:SSNC) has outperformed the market over the past decade with an average annual return of 13.18%, resulting in a $100 investment growing to $339.01. The article highlights the power of compounded returns.

Portfolio Pulse from Benzinga Insights

October 10, 2024 | 7:31 pm

ABBV

AbbVie (NYSE:ABBV) has outperformed the market over the past 10 years with an average annual return of 13.48%, resulting in a $100 investment growing to $357.27. The article highlights the impact of compounded returns over time.

Portfolio Pulse from Benzinga Insights

October 10, 2024 | 7:31 pm

INCY

Incyte Inc. (NASDAQ:INCY) stock is currently priced at $64.92, experiencing a 1.28% drop in the current session. Despite this, the stock has risen by 2.46% over the past month and 12.69% over the past year. The company's P/E ratio of 160.39 is significantly higher than the Biotechnology industry average of 50.65, suggesting potential overvaluation or expected future performance. Investors are advised to consider the P/E ratio alongside other financial metrics and qualitative analysis.

Portfolio Pulse from Benzinga Insights

October 10, 2024 | 7:30 pm

IDR

Idaho Strategic Resources shares rose following the announcement of a new high-grade gold discovery and preliminary highlights from the Golden Chest 2024 summer drill program.

Portfolio Pulse from Benzinga Newsdesk

October 10, 2024 | 7:28 pm